Jaguar Health, Inc.
JAGX
$2.23
-$0.005-0.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.46M | -9.92M | -9.85M | -9.49M | -9.23M |
| Total Depreciation and Amortization | 546.00K | 593.00K | 596.00K | 559.00K | 610.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 274.00K |
| Total Other Non-Cash Items | 1.28M | 2.94M | 3.10M | 2.00M | 1.45M |
| Change in Net Operating Assets | 1.32M | -1.44M | -178.00K | -1.24M | -153.00K |
| Cash from Operations | -7.32M | -7.83M | -6.34M | -8.17M | -7.05M |
| Capital Expenditure | -- | 0.00 | 0.00 | -16.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -215.00K | -- | -- | -- |
| Cash from Investing | -- | -215.00K | 0.00 | -16.00K | -- |
| Total Debt Issued | 3.45M | -- | -- | -- | -- |
| Total Debt Repaid | -238.00K | -171.00K | -221.00K | -94.00K | -222.00K |
| Issuance of Common Stock | 1.77M | 3.03M | 3.77M | 12.74M | 12.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.00K | -30.00K | -18.00K | -67.00K | -42.00K |
| Cash from Financing | 4.97M | 2.83M | 3.53M | 12.57M | 12.27M |
| Foreign Exchange rate Adjustments | 36.00K | -56.00K | 31.00K | -10.00K | -19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.31M | -5.27M | -2.78M | 4.38M | 5.20M |